RxDoctor Payments DataLook up a doctor →

Jeffry Pilney

New Martinsville, WVNPI 1487601647

Payments from drug & device makers

$2,159,013in general payments, 2019–2025

Across 590 payments — averaging $3659.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$613K
  • Ipsen Innovation$359K
  • AbbVie$347K
  • Genentech, Inc.$272K
  • Modernatx, Inc.$230K
  • Orasure Technologies Inc.$110K
  • plus $228K from 5 others

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca28$612,915
Ipsen Innovation327$359,470
AbbVie109$346,594
Genentech, Inc.30$271,798
Modernatx, Inc.53$230,276
Orasure Technologies Inc.5$110,000
Chiesi USA, Inc.12$96,659
Pfizer8$79,550
GSK11$37,876
Eli Lilly3$8,994
Roche Molecular Systems, Inc.4$4,882

Where these figures come from

Is this you, or does something look wrong? →